EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses

Jiabao Tian, Camelia Quek

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiabao Tian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Melanoma, Skin Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is the leading cause of global skin cancer-related death and currently ranks as the third most commonly diagnosed cancer in Australia. Melanoma patients with in-transit metastases (ITM), a type of locoregional metastasis located close to the primary tumor site, exhibit a high likelihood of further disease progression and poor survival outcomes. Immunotherapies, particularly immune checkpoint inhibitors (ICI), have demonstrated remarkable efficacy in ITM patients with reduced occurrence of further metastases and prolonged survival. The major challenge of immunotherapeutic efficacy lies in the limited understanding of melanoma and ITM biology, hindering our ability to identify patients who likely respond to ICIs effectively. In this review, we provided an overview of melanoma and ITM disease. We outlined the key ICI therapies and the critical immune features associated with therapy response or resistance. Lastly, we dissected the underlying biological components, including the cellular compositions and their communication networks within the tumor compartment, to enhance our understanding of the interactions between immunotherapy and melanoma, providing insights for future investigation and the development of drug targets and predictive biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMelanomaSkin NeoplasmsTumor MicroenvironmentHumansImmunotherapyNeoplasm Metastasis

Stichwörter der Autor:innen

immune checkpoint inhibitorsimmunotherapy responsein-transit metastasesmelanomatumor microenvironment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Zitieren

APA

Tian, J., & Quek, C. (2024). Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084243

Vancouver

Tian J, Quek C. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084243

BibTeX
@article{Tian2024,
  author = {Tian, Jiabao and Quek, Camelia},
  title = {Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084243}
}
Kostenlos starten →